WallStreetZenWallStreetZen

NASDAQ: NUVL
Nuvalent Inc Stock Ownership - Who owns Nuvalent?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Nuvalent Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
James Richard PorterPresident and CEO2025-04-1510,987$68.31
$750.52kSell
James Richard PorterPresident and CEO2025-04-15488$70.73
$34.52kSell
James Richard PorterPresident and CEO2025-04-154,465$70.05
$312.77kSell
James Richard PorterPresident and CEO2025-04-1511,060$69.05
$763.69kSell
James Richard PorterPresident and CEO2025-04-1527,000$27.85
$751.95kBuy
Darlene NociChief Development Officer2025-03-27900$73.83
$66.45kSell
Darlene NociChief Development Officer2025-03-273,100$72.91
$226.02kSell
Darlene NociChief Development Officer2025-03-271,773$14.40
$25.53kBuy
Darlene NociChief Development Officer2025-03-272,227$18.93
$42.16kBuy
James Richard PorterPresident and CEO2025-03-1716,363$76.20
$1.25MSell

1 of 24

NUVL insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when NUVL insiders and whales buy or sell their stock.

NUVL Shareholders

What type of owners hold Nuvalent Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
James E. Flynn26.04%18,643,523$1.34BInsider
Deerfield Management Company LP Series C25.13%17,991,024$1.29BInstitution
Fmr LLC13.48%9,654,326$691.64MInstitution
Paradigm Biocapital Advisors LP7.49%5,363,379$384.23MInstitution
Vanguard Group Inc6.28%4,499,864$322.37MInstitution
Blackrock Inc5.38%3,851,577$275.93MInstitution
Perceptive Advisors LLC3.66%2,619,977$187.70MInstitution
Matthew Shair2.30%1,643,719$117.76MInsider
Commodore Capital LP2.26%1,621,600$116.17MInstitution
State Street Corp2.08%1,489,680$106.72MInstitution

1 of 3

NUVL vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NUVL74.75%25.25%Net SellingNet Selling
AXSM70.18%29.82%Net BuyingNet Buying
VRNA10.10%52.80%Net SellingNet Buying
ADMA78.41%21.59%Net SellingNet Selling
KRYS78.59%21.41%Net SellingNet Selling
View Top Biotech Stocks

Nuvalent Stock Ownership FAQ

Who owns Nuvalent?

Nuvalent (NASDAQ: NUVL) is owned by 98.58% institutional shareholders, 33.30% Nuvalent insiders, and 0.00% retail investors. James E. Flynn is the largest individual Nuvalent shareholder, owning 18.64M shares representing 26.04% of the company. James E. Flynn's Nuvalent shares are currently valued at $1.30B.

If you're new to stock investing, here's how to buy Nuvalent stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.